1-4 of 4
Brigitte C. Widemann
Close
Sort by
Journal Articles

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques

Anandani Nellan, Cynthia M. Lester McCully, Rafael Cruz Garcia, Nalini Jayaprakash, Brigitte C. Widemann, Daniel W. Lee, Katherine E. Warren
Journal: Blood
Blood (2018) 132 (6): 662–666.
https://doi.org/10.1182/blood-2018-05-846428
Published: 2018
Journal Articles

Pharmacokinetics and Tolerability of Etoposide in Newly Diagnosed Lymphoma Patients with Hepatic Impairment

Catherine Lai, MD MPH, Diane Cole, Nicole Lucas, RN, Seth M. Steinberg, PhD, Brigitte C Widemann, MD, Kieron Dunleavy, MD, Wyndham H Wilson, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4445.
https://doi.org/10.1182/blood.V124.21.4445.4445
Published: 2014
Journal Articles

Vincristine Sulfate Liposomes Injection (VSLI, Marqibo): Interim Results From a Phase I Study in Children and Adolescents with Refractory Cancer

Nirali N Shah, MD, Melinda Merchant, MD, PhD, Diane Cole, Kelly Richards, RN, Cindy Delbrook, RN, Brigitte C Widemann, MD, Alan S Wayne, MD
Journal: Blood
Blood (2012) 120 (21): 1497.
https://doi.org/10.1182/blood.V120.21.1497.1497
Published: 2012
Journal Articles

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma

Clinical Trials & Observations
Elizabeth Fox, Bassem I. Razzouk, Brigitte C. Widemann, Shaun Xiao, Michelle O'Brien, Wendy Goodspeed, Gregory H. Reaman, Susan M. Blaney, Anthony J. Murgo, Frank M. Balis, Peter C. Adamson
Journal: Blood
Blood (2008) 111 (2): 566–573.
https://doi.org/10.1182/blood-2007-08-107839
Published: 2008